HRR gene-mutated (HRRm) metastatic castration-resistant prostate cancer (mCRPC)
Also known as: HRRm mCRPC
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11760 | Talazoparib | A poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer and HRR gene-mutated metastatic castration-resistant prostate cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11760 | Talazoparib | Poly [ADP-ribose] polymerase 1 | target |
| DB11760 | Talazoparib | Poly [ADP-ribose] polymerase 2 | target |
| DB11760 | Talazoparib | P-glycoprotein 1 | transporter |
| DB11760 | Talazoparib | ATP-binding cassette sub-family G member 2 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|